Business Context and Reporting Period
Company: Universal Health Services, Inc. (UHS)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended September 30, 2025
Operations: UHS operates 374 inpatient facilities and 156 outpatient facilities across 39 U.S. states, Washington D.C., the United Kingdom, and Puerto Rico. The company operates through two reportable segments: Acute Care Hospital Services and Behavioral Health Care Services.
Key Financial Metrics
| Metric (in thousands) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Net Revenues | $4,495,245 | $3,963,027 | $12,878,781 | $11,714,213 |
| Income from Operations | $521,688 | $384,165 | $1,476,783 | $1,209,325 |
| Net Income Attributable to UHS | $372,957 | $258,714 | $1,042,855 | $809,700 |
| Diluted EPS | $5.86 | $3.80 | $16.07 | $11.88 |
| Operating Cash Flow (9M) | $1,289,704 | $1,408,664 | ||
| Total Debt (Carrying Value) | ~$4.7 billion (as of Sept 30, 2025) | |||
| Cash & Equivalents | $112,895 (Current); $216,603 (Total incl. restricted) | |||
Margins (Q3 2025): Operating margin was 11.6%; Net income margin attributable to UHS was 8.3%.
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 13.4% in Q3 2025 and 9.9% for the nine-month period compared to 2024. Growth was driven by a 11.3% increase in "Same Facility" revenues and contributions from two newly opened acute care hospitals (West Henderson Hospital in Nevada and Cedar Hill Regional Medical Center in Washington, D.C.).
- Profitability: Net income attributable to UHS increased 44% in Q3 and 29% for the nine-month period. This was primarily due to higher pre-tax income and a decrease in interest expense.
- Interest Expense: Net interest expense decreased 14% in Q3 and 22% for the nine-month period, driven by a lower average cost of borrowings (4.1% in 9M 2025 vs. 5.0% in 9M 2024) following debt refinancing in September 2024.
- Legal Reserves: The company recorded an $18 million legal reserve in Q3 2025 related to a verdict in the Pinnacle litigation in Nevada. Additionally, $35 million was recorded in reserves for self-insured professional and general liability claims for both Q3 and 9M 2025 due to unfavorable trends.
- Medicaid Supplemental Payments: A significant $90 million benefit was recorded in Q3 2025 related to a Washington, D.C. Medicaid state-directed payment program.
Guidance, Outlook, Risks, and Unusual Items
- Capital Expenditures: UHS expects to spend approximately $1.0 billion to $1.1 billion on capital expenditures for the full year 2025. Approximately $734 million was spent in the first nine months, with $266 million to $366 million expected for the remainder of the year.
- Legislative Risks (OBBBA): The "One Big Beautiful Bill Act" (OBBBA), enacted July 4, 2025, introduces work requirements for Medicaid eligibility and caps provider taxes. Management estimates this could reduce aggregate annual net benefit from Medicaid supplemental programs by $420 million to $470 million by 2032.
- Legal Contingencies:
- Cumberland Litigation: A jury verdict in September 2024 awarded plaintiffs $60 million in compensatory damages and $180 million in trebled damages (punitive damages reduced to $1.05 million by the court). Approximately 40 additional plaintiffs remain pending. The company has ~$147 million in remaining commercial insurance coverage for the 2020 policy year.
- Pinnacle Litigation: A September 2025 verdict awarded $4.7 million in compensatory damages and $500 million in punitive damages (expected to be reduced to ~$14 million). The company is appealing.
- Insurance Changes: Effective March 2025, commercial insurance coverage includes exclusions for sexual molestation/abuse, higher premiums, and lower aggregate limitations.
- Stock Repurchases: On October 27, 2025, the Board authorized a $1.5 billion increase to the stock repurchase program, bringing the total available authorization to $1.759 billion.
Investor Verification Checklist
- Medicaid Revenue Sustainability: Verify the long-term viability of state-directed payment programs (particularly in Texas, Nevada, and Washington D.C.) given the new federal caps and work requirements under the OBBBA.
- Legal Exposure: Monitor the status of the Cumberland and Pinnacle litigation appeals and the potential impact on insurance coverage limits and future reserves.
- Debt Maturity Profile: Review the $740 million in debt due within the next 12 months and the company's ability to refinance or repay using operating cash flows.
- Same-Facility Growth: Assess whether the 11.3% same-facility revenue growth is sustainable without the one-time $90 million D.C. Medicaid benefit.
- Interest Rate Sensitivity: Evaluate the impact of potential future interest rate increases on the variable-rate portions of the credit facility and term loans.